Brain monoamine oxidase activity after chronic ethanol treatment of rats.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 407593)

Published in Psychopharmacology (Berl) on April 29, 1977

Authors

A Wiberg, G Wahlstroöm, L Oreland

Articles by these authors

Genetical studies of spontaneous sources of resistance to powdery mildew in barley. Hereditas (1974) 1.40

Human brain contains high levels of heteroplasmy in the noncoding regions of mitochondrial DNA. Proc Natl Acad Sci U S A (1996) 1.38

Investigation of the functional effect of monoamine oxidase polymorphisms in human brain. Hum Genet (2001) 1.20

A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. J Psychiatr Res (2000) 1.19

Markers for vulnerability to psychopathology: temperament traits associated with platelet MAO activity. Acta Psychiatr Scand (1987) 1.13

Platelet MAO activity as a biological marker in subgroups of alcoholism. Acta Psychiatr Scand (1985) 1.13

Does Swedish amateur boxing lead to chronic brain damage? 1. A retrospective medical, neurological and personality trait study. Acta Neurol Scand (1990) 1.13

Human fear conditioning is related to dopaminergic and serotonergic biological markers. Behav Neurosci (2001) 1.08

The effect of age on the activity and molecular properties of human brain monoamine oxidase. J Neural Transm (1980) 1.08

Alcoholics with reduced dopamine D2 receptor function possess normal platelet monoamine oxidase activity. Alcohol Alcohol (1994) 1.07

Personality traits and platelet MAO activity in alcohol and drug abusing teenage boys. Acta Psychiatr Scand (1987) 1.07

Maltreatment, MAOA, and delinquency: sex differences in gene-environment interaction in a large population-based cohort of adolescents. Behav Genet (2010) 1.06

Immunology in the clinic review series: focus on type 1 diabetes and viruses: the role of viruses in type 1 diabetes: a difficult dilemma. Clin Exp Immunol (2012) 1.03

Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus. Brain Res Brain Res Rev (2001) 1.02

Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study. J Psychiatr Res (1986) 0.99

Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics. Genomics (1995) 0.98

Monoamine oxidase-B in astrocytes. Glia (1993) 0.97

Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism. Adv Biochem Psychopharmacol (1980) 0.97

Purification and properties of pig liver mitochondrial monoamine oxidase. Arch Biochem Biophys (1971) 0.97

Changes in uptake of vitamin B(12) and trace metals in brains of mice treated with clioquinol. J Neurol Sci (2000) 0.96

Mitochondrial enzyme deficiencies in Down's syndrome. J Neural Transm Park Dis Dement Sect (1994) 0.94

Facial spasm. With special reference to the chorda tympani function and operative treatment. Laryngoscope (1967) 0.94

Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT). Neurobiol Aging (1983) 0.91

Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci (1980) 0.91

Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in Type 2 diabetes mellitus complicated by retinopathy. Diabet Med (1999) 0.90

Low platelet monoamine oxidase activity in cigarette smokers. Life Sci (1981) 0.88

A histochemical demonstration of altered cytochrome oxidase activity in the rat brain by neuroleptics. Eur Neuropsychopharmacol (1998) 0.87

Neuroleptic-induced mitochondrial enzyme alterations in the rat brain. J Pharmacol Exp Ther (1997) 0.87

Methodological aspects for in vitro characterization of receptor binding using 11C-labeled receptor ligands: a detailed study with the benzodiazepine receptor antagonist [11C]Ro 15-1788. Nucl Med Biol (1997) 0.87

Low platelet monoamine oxidase activity in human alcoholics. Med Biol (1977) 0.87

Genetic mechanisms of behavior--don't forget about the transcription factors. Mol Psychiatry (2001) 0.87

Chronic mild unpredictable stress after noradrenergic denervation: attenuation of behavioural and biochemical effects of DSP-4 treatment. Eur Neuropsychopharmacol (1999) 0.86

Monoamine oxidase activity and localisation in the brain and the activity in relation to psychiatric disorders. Mod Probl Pharmacopsychiatry (1983) 0.86

Monoamine oxidase B in brains from patients with Alzheimer's disease: a biochemical and autoradiographical study. Neuroscience (1991) 0.85

Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistry. Brain Res (2001) 0.85

Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls. Psychiatry Res (1981) 0.85

Dose-dependent effects of noradrenergic denervation by DSP-4 treatment on forced swimming and beta-adrenoceptor binding in the rat. J Neural Transm (Vienna) (1999) 0.85

Substrate- and stereoselective inhibitor of human brain monoamine oxidase by 4-dimethylamino-alpha, 2-dimethylphenethylamine (FLA 336). J Pharm Pharmacol (1981) 0.85

Morbidity risk for psychiatric disorders in families of probands with affective disorders divided according to levels of platelet MAO activity. Psychiatry Res (1985) 0.85

Lesioning of locus coeruleus projections by DSP-4 neurotoxin treatment: effect on amphetamine-induced hyperlocomotion and dopamine D2 receptor binding in rats. Pharmacol Toxicol (2000) 0.85

The effect of deprenyl (selegiline) on intra- and extraneuronal dopamine oxidation. Acta Neurol Scand Suppl (1983) 0.85

Thrombocyte monoamine oxidase activity and personality traits in women with severe premenstrual syndrome. Acta Psychiatr Scand (1987) 0.85

Levels of L-methionine S-adenosyltransferase activity in erythrocytes and concentrations of S-adenosylmethionine and S-adenosylhomocysteine in whole blood of patients with Parkinson's disease. Exp Neurol (1997) 0.84

Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics. Neuropsychopharmacology (2000) 0.84

The development of mental state attributions in women with X-monosomy, and the role of monoamine oxidase B in the sociocognitive phenotype. Cognition (2006) 0.84

Chronic citalopram treatment induces time-dependent changes in the expression and DNA-binding activity of transcription factor AP-2 in rat brain. Eur Neuropsychopharmacol (2003) 0.84

Quantitative localization of human brain monoamine oxidase B by large section autoradiography using L-[3H]deprenyl. Brain Res (1991) 0.84

Studies on semicarbazide-sensitive amine oxidase in patients with diabetes mellitus and in transgenic mice. Biochim Biophys Acta (2003) 0.84

Levels of transcription factors AP-2alpha and AP-2beta in the brainstem are correlated to monoamine turnover in the rat forebrain. Neurosci Lett (2001) 0.83

Effect of reserpine on the brain uptake of carbon 11 methamphetamine and its N-propagyl derivative, deprenyl. Eur J Nucl Med (1990) 0.83

Platelet monoamine oxidase activity is related to MAOB intron 13 genotype. J Neural Transm (Vienna) (2000) 0.83

Effect of lipid-depletion on the different forms of monoamine oxidase in rat liver mitochondria. Biochem Pharmacol (1976) 0.83

Brain and brain monoamine oxidase in aging and in dementia of Alzheimer's type. Prog Neuropsychopharmacol Biol Psychiatry (1986) 0.83

Autoradiographic imaging of formaldehyde adducts in mice: possible relevance for vascular damage in diabetes. Life Sci (1998) 0.83

A polymorphic region in the human transcription factor AP-2beta gene is associated with specific personality traits. Mol Psychiatry (2000) 0.83

MPTP toxicity in relation to age, dopamine uptake and MAO-B activity in two rodent species. Pharmacol Toxicol (1989) 0.83

Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics. Neuropsychopharmacology (1999) 0.83

Sources of resistance to powdery mildew in barley. Hereditas (1974) 0.83

Lowered monoamine oxidase activity in brains from alcoholic suicides. J Neurochem (1975) 0.83

Regulation of methionine adenosyltransferase catalytic activity and messenger RNA in SH-SY5Y human neuroblastoma cells. Biochem Pharmacol (1998) 0.82

Plasma levels and clinical effects of thioridazine and thiothixene. J Clin Pharmacol (1975) 0.82

Chronic pharmacological treatment with certain antidepressants alters the expression and DNA-binding activity of transcription factor AP-2. Life Sci (2000) 0.82

Platelet monoamine oxidase activity in type 1 and type 2 alcoholism. Alcohol Alcohol (1991) 0.82

Neuropsychological correlates of platelet monoamine oxidase (MAO) activity in female and male subjects. Biol Psychol (1987) 0.81

Effect of the GABA-transaminase inhibitor vigabatrin on exploratory behaviour in socially isolated rats. Behav Brain Res (1995) 0.81

Reassociation of soluble monoamine oxidase with lipid-depleted mitochondria in the presence of phospholipids. Biochemistry (1971) 0.81

Release of dopamine by perfusion with 1-methyl-4-phenylpyridinium ion (MPP(+)) into the striatum is associated with hydroxyl free radical generation. Brain Res (2001) 0.81

The nature of the substrate-selective interaction between rat liver mitochondrial monoamine oxidase and oxygen. Biochem Pharmacol (1980) 0.81

Titration of human brain type-B monoamine oxidase. Neurochem Res (1980) 0.81

Personality traits related to monoamine oxidase activity in platelets. Psychiatry Res (1984) 0.81

Pentametric distribution of platelet monoamine oxidase activity. Psychiatry Res (1985) 0.81

Staurosporine differentiated human SH-SY5Y neuroblastoma cultures exhibit transient apoptosis and trophic factor independence. Brain Res Bull (1997) 0.80

Personality traits and platelet monoamine oxidase activity in alcoholic women. Addict Behav (1991) 0.80

Changes in psychopathology in relation to EEG variables and visual averaged evoked responses (V.AER) in schizophrenic patients treated with penfluridol or thiothixene. Acta Psychiatr Scand (1977) 0.80

Two-fold transmission reach enhancement enabled by transmitter-side digital backpropagation and optical frequency comb-derived information carriers. Opt Express (2015) 0.80

Effect of age on human brain serotonin (S-1) binding sites. J Neurochem (1984) 0.80

Decreased methionine adenosyltransferase activity in erythrocytes of patients with dementia disorders. Eur Neuropsychopharmacol (1995) 0.80

The interaction between human platelet monoamine oxidase, its monoamine substrates and oxygen. Biochem Pharmacol (1979) 0.80

5-HIAA and HVA in CSF in patients with idiopathic pain disorders. Biol Psychiatry (1987) 0.80

Brain gamma-aminobutyrate transaminase and monoamine oxidase activities in suicide victims. Eur Arch Psychiatry Clin Neurosci (1991) 0.80

The uptake of serotonin and dopamine by homogenates of frozen rat and human brain tissue. Neurochem Res (1985) 0.80

The genotype of human transcription factor AP-2beta is associated with platelet monoamine oxidase B activity. Neurosci Lett (2000) 0.80

Clinical characteristics and biological parameters in temperamental clusters of suicide attempters. J Affect Disord (1997) 0.80

Platelet monoamine oxidase activity in sensation seekers. Psychiatry Res (1980) 0.80

Neuropeptide Y attenuates the effect of locus coeruleus denervation by DSP-4 treatment on social behaviour in the rat. Neuropeptides (2000) 0.80

2-Bromoethylamine, a suicide inhibitor of tissue-bound semicarbazide-sensitive amine oxidase. Jpn J Pharmacol (2000) 0.80

Some properties of monoamine oxidase and a semicarbazide sensitive amine oxidase capable of the deamination of 5-hydroxytryptamine from porcine dental pulp. Biochem Pharmacol (1982) 0.79

Low B12 levels related to high activity of platelet MAO in patients with dementia disorders. A retrospective study. Acta Psychiatr Scand (1988) 0.79

Importance of genetic effects for monoamine oxidase activity in thrombocytes in twins reared apart and twins reared together. Psychiatry Res (1993) 0.79

Tomographic examination of the vertical part of the facial canal in cases of Bell's palsy. Acta Otolaryngol (1975) 0.79

Pedunculated tumours of the oesophagus. Two cases of lipoma. Acta Radiol Diagn (Stockh) (1974) 0.79

Prediction of suicidal behavior from biologic tests. J Clin Psychopharmacol (1992) 0.79

Follow-up of plasma semicarbazide-sensitive amine oxidase activity and retinopathy in Type 2 diabetes mellitus. J Diabetes Complications (2001) 0.79